Cartesian Therapeutics, Inc. - RNAC

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Apr 02, 2026 SCHEDULE 13D/A 19.9% View
Mar 13, 2026 SCHEDULE 13G Squarepoint Ops LLC 8.3% 2,209,601 View
Mar 13, 2026 SCHEDULE 13G Squarepoint Capital LLP 8.3% 2,209,601 View
Mar 13, 2026 SCHEDULE 13G Squarepoint Operations Private Limited 8.3% 2,209,601 View
Mar 13, 2026 SCHEDULE 13G Squarepoint (DIFC) Ltd 8.3% 2,209,601 View
Mar 13, 2026 SCHEDULE 13G Squarepoint Master Fund Limited 8.2% 2,178,652 View
Mar 13, 2026 SCHEDULE 13G Squarepoint Core Master Fund Limited 0.1% 30,949 View
Feb 05, 2026 SCHEDULE 13G/A FMR LLC 5.3% 1,366,989 View
Feb 05, 2026 SCHEDULE 13G/A Abigail P. Johnson 5.3% 1,366,989 View
Nov 05, 2025 SCHEDULE 13G/A FMR LLC 8.3% 2,155,783 View
Nov 05, 2025 SCHEDULE 13G/A Abigail P. Johnson 8.3% 2,155,783 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.